Delivery Order SPE2DB20D7059-SPE2DB25FGRK9
- Not listed
- The Defense Logistics Agency awarded a $6,908.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Arimidex 1 mg, with an ultimate completion date of August 4, 2025. This non-set-aside contract was competitively awarded and is to be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with the agency. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.92 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on September 7, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,421.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.66 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging). The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award is issued as a child order under the company's larger...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,925.36 contract is for the delivery of 4,567,937,962 units of the pharmaceutical product Arimidex 1 mg tablets. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,690.72, is for the delivery of 4,568,092,832 tablets of the prescription medication Arimidex (1 mg). The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,802.19 firm fixed-price delivery order is for the supply of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $4,802.19 and an ultimate completion date of November 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,512.79 firm fixed price contract is for the delivery of ARIMIDEX 1 MG TABLET 30S. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DB20D2200|SPE2DB25FW62L, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,118.58 firm fixed-price delivery order is for the supply of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $29,866.36 and a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRK9Delivery Order
The Defense Logistics Agency awarded a $2,719.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Arimidex 1 mg tablets. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and represents a non-competitive, non-set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location at the same address. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The Arimidex order exemplifies the routine pharmaceutical procurement that flows through this master contract vehicle, which provides the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with access to both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/10/25 |